Ahmad Al Sadat, MD
Neurology · Murray, UTNPI 1104828987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $348 and has fallen 87.9% since, to $42 in 2025. That places this record below the midpoint for neurology clinicians in UT, where the typical reported total is $626.
Across 47 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$159
- Teva Pharmaceuticals USA, Inc.$126
- E.r. Squibb & Sons, L.L.C.$97
- AbbVie$79
- EMD Serono, Inc.$69
- SK Life Science, Inc.$68
- plus $252 from 8 others
What the payments were for
- Food & beverage$851100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 1 | $159 |
| Teva Pharmaceuticals USA, Inc. | 29 | $126 |
| E.r. Squibb & Sons, L.L.C. | 1 | $97 |
| AbbVie(2 entities) | 5 | $79 |
| EMD Serono, Inc. | 2 | $69 |
| SK Life Science, Inc. | 1 | $68 |
| Lundbeck LLC | 1 | $64 |
| Lilly USA, LLC | 1 | $60 |
| MDD US Operations, LLC | 1 | $48 |
| Greenwich Biosciences, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$159
How this compares
$851 in reported general payments places this provider in the 50th percentile of 157 neurology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 35 | $279 |
| ClopidogrelClopidogrel Bisulfate | 22 | $98 |
Paid to pharmacies, not to this prescriber.
Other neurology in Murray
- Nigel HarrisonMurray$41K
- Michael HunterMurray$33K
- Heston ArnoldMurray$20K
- Evan BlackMurray$15K
- Maya ThomasMurray$3K
- Kathleen McKeeMurray$3K
- Timothy WestSalt Lake City$856K
- Richard HammondOgden$707K
- Jeffrey GrovesDraper$628K
- Stacey SteevesSalt Lake City$548K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.